1. P520 Thromboembolic and major adverse cardiovascular events among patients in the filgotinib clinical trial programme. (30th January 2023) Authors: van der Woude, J; Schreiber, S; Peyrin-Biroulet, L; Szekanecz, Z; Choy, E H; Stiers, P J; Van Hoek, P; Van Beneden, K; de Haas, A; Rudolph, C; ten Cate, H Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗